相关产品推荐更多 >

CYP2R1 MaxPab小鼠源多克隆抗体(B01)/CYP2R1 MaxPab小鼠源多克隆抗体(B01)/CYP2R1 MaxPab小鼠源多克隆抗体(B01)
询价
RDX polyclonal antibody/RDX polyclonal antibody/RDX polyclonal antibody
询价
THRA 多克隆抗体
询价
LRRFIP1单克隆抗体/LRRFIP1单克隆抗体/LRRFIP1单克隆抗体
询价
IFNA10 (Human) IP-WB Antibody Pair/IFNA10 (Human) IP-WB Antibody Pair/IFNA10 (Human) IP-WB Antibody Pair
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
查看datasheet
- 保质期:
1年
- 级别:
科研级别
- 库存:
100
- 供应商:
艾美捷科技
- 应用范围:
查看datasheet
- 抗体英文名:
Human N Acetylglucosamine Kinase Antibody
- 抗体名:
Human N Acetylglucosamine Kinase Antibody
Human N Acetylglucosamine Kinase 抗体,Human N Acetylglucosamine Kinase Antibody,
产品名称:Human N Acetylglucosamine Kinase 抗体-Human N Acetylglucosamine Kinase Antibody
产品货号:BGT-ANT-30496
产品规格:150ug

应用类型:Human N Acetylglucosamine Kinase 抗体产品详情查看提供的产品datasheet。

Human N Acetylglucosamine Kinase 抗体,Human N Acetylglucosamine Kinase Antibody

Human N Acetylglucosamine Kinase 抗体-Human N Acetylglucosamine Kinase AntibodyHuman N Acetylglucosamine Kinase 抗体产品保存方式查看提供的产品datasheet。
点击:Human N Acetylglucosamine Kinase 抗体-Human N Acetylglucosamine Kinase Antibody更多Biogradetech产品信息价格,货期,产品说明,百度搜“艾美捷科技”进入官网网站,查看具体产品且快速下单。

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Detection and Analysis of (O-linked -N-Acetylglucosamine)-Modified Proteins
, the most widespread of which is the modification of Ser/Thr residues with monosaccharides of O-linked β-N -acetylglucosamine (O-GlcNAc). O-GlcNAc modification is concentrated in nuclear proteins. O-GlcNAc is thought to regulate protein function in a manner analogous
人 Neuritin 酶联免疫分析(ELISA) 试剂盒使用说明书 本试剂仅供研究使用 目的:本试剂盒用于测定人血清,血浆及相关液体样本 中Neuritin 的含量。 实验原理: 本试剂盒应用双抗体夹心法测定标本中人 Neuritin 水平。用纯化的 Neuritin 抗体 包被微孔板,制成固相抗体,往包被单抗的微孔中加入 Neuritin ,再与 HRP 标记的 Neuritin 抗体结合,形成抗体
Introduction of human 14-3-3 proteins
-3-3 family of proteins plays a role in a wide variety of cellular functions including regulation of protein kinase C and exocytosis.Using antisera specific for the N termini of 14-3-3 isoforms described previously and an additional antiserum specific
技术资料暂无技术资料 索取技术资料





